Photon Biosciences LLC

Pullman, WA · Medtech · Private

RECAL®, a non-photobleaching luminescent protein platform for detecting bacterial contamination in platelet transfusions

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Pullman, WA
Total capital: $1.4M

Federal grants: $1.4M; 6 awards · 2018–2024; Rank in peer group#19 of 28
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 1 pending

Capital timeline

Latest events

Jan 2024Federal grantHealth and Human S · Phase I · A Biosinpired Genetically-Expressible Dual-Modality Peptide-Based Probe for Super-Resolution Correlative Light and Electron Microscopy$300K
Jul 2022Federal grantHealth and Human S · Phase I · A Genetically Encoded Phosphorescent, Electron Dense Probe for Correlative Light and Electron Microscopy$299K
May 2020Federal grantHealth and Human S · Phase I · Ultra-sensitive rapid test for detecting bacterial contamination in platelets$265K
May 2020Federal grantHealth and Human S · Phase I · Ultra-sensitive rapid test for detecting bacterial contamination in platelets$265K
Apr 2018Federal grantHealth and Human S · Phase I · RECAL:A New Tool for Disease Detection and Biomolecular Imaging$150K
Mar 2018Federal grantHealth and Human S · Phase I · RECAL®: A New Tool for Disease Detection and Biomolecular Imaging$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 28 peers

Line = median

Medtech · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 1

PendingLuminescent Metal Binding Proteins And Peptides For Use In MicroscopyUSPTOApplication PCTUS2024019269

ACCELEREYES, LLCSimilar federal contract value in Medtech · null in contracts
Clear Health Pass Holdings LLCSimilar federal contract value in Medtech · null in contracts
Diversified 3D Technologies, Inc.Similar federal contract value in Medtech · null in contracts
Augnition Labs LLCSimilar federal contract value in Medtech · null in contracts
Food Allergy InstituteSimilar federal contract value in Medtech · null in contracts
PulsedLogic Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.